SUMMARY The concentrations of gold in erythrocytes, whole blood, cell-rich plasma, and cell-free plasma were investigated in 17 patients with rheumatoid arthritis undergoing long-term chrysotherapy. Gold estimations were performed with a graphite tube atomic absorption spectrophotometer. Significant quantities of gold were found in isolated erythrocytes of 12 patients. There was no correlation between erythrocyte gold and therapeutic response, plasma gold, and gold in whole blood. Nor did gold in whole blood or plasma show any correlation with therapeutic response and toxic reaction. However, all patients (3) with toxic reactions had a significantly higher gold concentration in the erythrocytes than the patients without toxic reactions. This result indicates that erythrocyte gold estimations could provide a useful warning of impending toxic reactions.
During the 50 years gold salts have been used for the treatment of patients with rheumatoid arthritis several investigators have searched for methods to improve drug efficacy while reducing undesirable toxic effects. Especially since the introduction of atomic absorption spectroscopy, which makes routine estimation of gold in biological fluids practicable, great attention has been focused on the determination of gold in serum or plasma to obtain an objective indicator of prognosis and clinical efficacy. Most (Table 2 ). The erythrocyte gold concentrations were found to be uncorrelated with Severe joint pain M =Myocrisin. S =Sanocrysin. RBC=red blood cells. *The precision ofeach gold concentration is + 2 g/l00 ml or less. **The precision of each gold concentration is + S gg/100 ml or less. S1 conversion: gold pg/l=pg/l00 ml x 10.
group.bmj.com on October 21, 2017 -Published by http://ard.bmj.com/ Downloaded from the activity of the disease as measured by ESR at the time of investigation. It is noteworthy, however, that a strong correlation between erythrocyte gold concentration and toxic reactions was found. The concentration of gold in erythrocytes was significantly higher in patients with toxic reactions than in those patients without toxic reactions (P<0 01). All patients with an erythrocyte gold concentration smaller than or equal to 36 tg/100 ml of washed erythrocyte fraction showed no toxic reactions, while all patients with an erythrocyte gold concentration larger than or equal to 56 tg/100 ml had current toxic reactions (Table 1) . Patients 15 and 16 had dermatitis, and the patient 17 suffered such severe and prolonged joint pain in relation to the gold injections that it was necessary to reduce the gold dosage by 500% to enable the gold therapy to continue. Although the number of patients in the toxic group is small and a larger group needs to be studied for confirmation of these results, it is statistically significant that toxic reactions developed when the erythrocyte gold concentration exceeded a critical value about 40-50 stg/100 ml (400-500 ,tg/l) of washed erythrocyte fraction.
With respect to plasma and whole blood gold concentrations no correlation to activity of the disease was seen. Similarly, there were no significantly raised gold concentrations in plasma and whole blood in the 3 patients suffering from toxic reactions (P>O-1). SI conversion: gold pg/l=pg/l00 ml x 10.
We found that the gold concentrations in erythrocytes determined by an indirect and a direct method corresponded well with each other (Table 3) Gold in erythrocytes, whole blood, and plasma daring long-term chrysotherapy 579 was found between a high concentration of gold in the red cell fraction and current toxicity. In agreement with the hypothesis it would not be unexpected if, in excess of a certain amount of gold (threshold value), toxic reactions appeared.
It is worth noting that retrospective analysis of the patients studied showed no obvious differences with respect to previous incidence and severity of adverse reactions. This might support the interpretation that the amount of gold in the red cell fraction reflects a certain actual concentration of gold in the bone marrow rather than an individual ability or inability to incorporate gold into erythrocytes. This question, however, needs to be elucidated by appropriate prospective studies.
It is uncertain whether gold is bound to the surface of the red cells in the circulation or is incorporated into the red cell precursors in the bone marrow. The last possibility, suggested and supported by the observations of Smith et al.,12 is consistent with our data. In accordance with previous reports2 3 >-we found no correlation between whole blood and plasma gold concentrations and current toxicity.
Our results indicate that the quantitative determination of gold in erythrocytes might provide a useful warning of impending toxic reactions during chrysotherapy. Contrary to this, the determination of gold in whole blood and plasma does not appear to be a useful guide to safe therapy.
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